1 QinG,ShaoJG,ZhuYC,et al.Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study[J].J Clin Gastroenterol,2016,50(8):670-675.
2 ThriftAP,El-SeragHB,KanwalF.Global epidemiology and burden of HCV infection and HCV-related disease[J].Nat Rev Gastroenterol Hepatol,2017,14(2):122-132.
3 LaniniS,EasterbrookPJ,ZumlaA,et al.Hepatitis C: global epidemiology and strategies for control[J].Clin Microbiol Infect,2016,22(10):833-838.
4 林秀蓉,陈巧绘,林海.TaqMan-MGB探针对HCV基因的检测及分型研究[J].东南国防医药,2012,14(1):20-22.
5 樊圆圆,岳明.核因子-κB信号通路与丙肝病毒感染相关性的研究进展[J].医学研究生学报,2019,32(3):293-297.
6 KhanST,KargesW,CooperCL,et al.Hepatitis C virus core protein reduces CD8+T-cell proliferation,perforin production and degranulation but increases STAT5 activation[J].Immunology,2017,154(1):156-165.
7 ParkSH,RehermannB.Immune responses to HCV and other hepatitis viruses[J].Immunity,2014,40(1):13-24.
8 HornerSM,GaleM.Regulation of hepatic innate immunity by hepatitis C virus[J].Nat Med,2013,19(7):879-888.
9 张继明.慢性丙型肝炎的肝外表现及处理[J].世界华人消化杂志,2004,12(10):140-143.
10 魏来.丙型肝炎的实验室诊断和临床意义[J].世界华人消化杂志,2004,12(10):111-114.
11 陈新月,任姗.《丙型肝炎防治指南》(2015年更新版)解读[J].北京医学,2015,37(12):1186-1188.
12 Vallet-PichardA,MalletV,NalpasB,et al.FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection.comparison with liver biopsy and fibrotest[J].Hepatology,2007,46(1):32-36.
13 RehermannB.Interaction between the hepatitis C virus and the immune system[J].Semin Liver Dis,2000,20(2):127-141.
14 HajarizadehB,GrebelyJ,DoreGJ.Epidemiology and natural history of HCV infection[J].Nat Rev Gastroenterol Hepatol,2013,10(9):553-562.
15 汤伟,沈轶瑶,徐芳芹.病毒性肝炎患者四项血常规参数临床意义的再评价[J].热带医学杂志,2004,4(5):546-548.
16 Nichols BA,BaintonDF,FarquharMG.Differentiation of monocytes.Origin,nature,and fate of their azurophil granules[J].J Cell Biol,1971,50(2):498-515.
17 DolganiucA,ChangS,KodysK,et al.Hepatitis C virus (HCV) core protein-induced,monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection[J].J Immunol,2006,177(10):6758-6768.
18 魏新素,张平安,吴泽刚.丙型肝炎病毒感染者血小板参数、凝血功能的分析[J].职业与健康,2011,27(19):2202-2203.
19 Vallet-PichardA,MalletV,PolS.FIB-4: a simple,inexpensive and accurate marker of fibrosis in HCV-infected patients[J].Hepatology,2006,44(3): 769-770.
20 谷娅楠,朱鸿,程艳杰,等.丙型肝炎患者血清HCV-RNA载量、抗-HCV及ALT的相关性研究[J].国际检验医学杂志,2014,35(4):487-488.
21 张瑾,张娟,薛晓宁,等.血清HCV RNA载量、HCV抗体及ALT相关性研究[J].中国国境卫生检疫杂志,2017,40(2):83-86.
[1]林秀蓉,陈巧绘,林 海.TaqMan-MGB探针对HCV基因的检测及分型研究[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):20.
LIN Xiu-rong,CHEN Qiao-hui,LIN Hai..Study on rapid detecting and genotyping of HCV gene by TaqMan-MGB probes[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(5):20.